Back to homepage


SERIES assumes that continuous improvement in its performance can only be achieved through the enhancement and training of its technical staff, as well as the adoption of a proactive attitude of continuous improvement. In this sense the following commitments have been defined:

1- To ensure that the employees and other interested parties are adequately trained, aware and well informed in order to guarantee greater motivation, environmental awareness, as well as the promotion of a safety and health at work culture.

2- To value a continuous improvement in the relationship with every party, namely customers, suppliers, partners and reference entities in the business.

3- To carry out the business in accordance with legal obligations, licenses, contracts and other subscribed obligations, with the management committing to ensure the necessary resources for compliance.

4- To monitor and review the environmental management system, namely the environmental objectives, in order to ensure its continuous improvement and improve environmental performance.

5- To minimize the environmental impact resulting from the company's activity, namely by ensuring the maximum usage of recyclable resources.

6- To eliminate hazards and to reduce risks to safety and health at work.

7- To contribute to the sustainable development of the company, through a commitment to continuous protection of the environment and employees.

SERIES Internal Sustainable Development References

  • SERIES Code of Ethics
  • Supplier Code of Conduct
  • Stakeholder Relationship Policy
  • SERIES Environmental and Social Responsibility Policy

Social Responsibility Policy

SERIES has long believed that each company also plays an important social role. That is why since 2012 we have been regularly supporting AETN - Associação de Esclerose Tuberosa in Portugal, an association of patients suffering from tuberous sclerosis. Tuberous Sclerosis is a genetic disease that results from mutations in the TSC1, which encodes hamartin, and TSC2, which encodes tuberin, genes. These mutations enhance the development of benign tumors in vital organs such as the heart, eyes, brain, kidneys, lungs and skin. The growth of these tumors reveals an aggressive behavior because it threatens the function of the affected organs. Two-thirds of the diagnoses are new cases of the disease without any family history, and one-third are hereditary cases. When it manifests, the disease can cause epilepsy, autism or cognitive impairment.

Despite being a rare disease, it impacts not only the patient but the entire group that supports him. The A.E.T.N. was born from the willingness of a group of parents and relatives to improve the quality of life of these patients. Learn more about AETN here: